Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Case Study: Benefits of Post-Acute Nursing Facility vs. Home Care

When a patient is released from the hospital, patient advocates often believe their best chance for recovery and avoidance of readmission is in-home medical care and rehabilitation versus admittance into a skilled nursing facility (SNF). During hospitalization, however, it’s challenging to envision the in-home post-acute care needs for each unique patient. Thus, it’s not a…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

When a patient is released from the hospital, patient advocates often believe their best chance for recovery and avoidance of readmission is in-home medical care and rehabilitation versus admittance into a skilled nursing facility (SNF). During hospitalization, however, it’s challenging to envision the in-home post-acute care needs for each unique patient. Thus, it’s not a simple narrative on which option will best facilitate a quick and full recovery.

The Determining Factors

To gain better insight, a study by Penn State University Leonard Davis Institute of Health Economics (LDI) looked to determine the differences in 30-day readmission rates, 30-day mortality rates, functional outcomes, and Medicare costs between those patients discharged to home health and those to an SNF. The assessment factors were unique in that the research used a large data set (17 million Medicare beneficiary hospitalizations), controls for patient characteristics across care settings, and included patients with many different ailments.

The Findings

During 2010 and 2016, of the more than 17 million discharges considered in the study, over 40% of the patients received some type of post-acute services—39% were released into a home care setting and 61% to an SNF. While those discharged to home rehab had a 5.6% higher readmission rate at 30 days than those in the SNF category, it is assumed that the 24-hour monitored care and higher level of treatment provided by an SNF reduced the likelihood of post-acute complications. However, the slightly higher readmission rates of home-recovery patients were not attributed to life-threatening symptoms such as respiratory failure but were based on potential cautionary reasons at the caregiver’s or patient’s discretion.

When it comes to costs, the average savings per patient discharged to in-home care was $5,385 less than patients admitted to SNFs. Further, the total Medicare payment within the first 60 days following hospitalization was also less for the home health care group, with a savings of $4,514 per patient. Interestingly enough, though, the study found no difference in improved patient functionality from the home health setting versus a SNF, nor were their disparities in mortality rates between each group. While the study correlates fewer readmissions with SNFs, these facilities did incur significantly increased Medicare spending per patient.

Clinicians must be able to balance the benefits of both settings to ensure the best outcome for their patients. Additional research to better understand which patient profiles would most benefit from SNF care or may be less likely to be readmitted after discharge to home health care could provide vital insight for caregivers and hospitals alike.

Help for Home Caretakers

When a patient is released to in-home care, their family or friends are often the ones tasked with helping in their recovery. This care typically involves changing dressings, managing medications, and the operation of fundamental medical equipment. AliMed is committed to providing patients and caregivers with a wide selection of quality at-home specialty healthcare products designed to improve quality of life and promote safer, easier, and more independent living. Click here to learn more.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512